Unbalanced X-chromosome inactivation in haemopoietic cells from normal women. 1998

L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
Department of Internal Medicine and Medical Therapy, University of Pavia Medical School and IRCCS Policlinico S. Matteo, Italy.

We studied X-chromosome inactivation patterns in blood cells from normal females in three age groups: neonates (umbilical cord blood), 25-32 years old (young women group) and >75 years old (elderly women). Using PCR, the differential allele methylation status was evaluated on active and inactive X chromosomes at the human androgen receptor (HUMARA) and phosphoglycerate kinase (PGK) loci. A cleavage ratio (CR) > or = 3.0 was adopted as a cut-off to discriminate between balanced and unbalanced X-chromosome inactivation. In adult women this analysis was also performed on hair bulbs. The frequency of skewed X-inactivation in polymorphonuclear (PMN) cells increased with age: CR > or = 3.0 was found in 3/36 cord blood samples, 5/30 young women and 14/31 elderly women. Mathematical analysis of patterns found in neonates indicated that X-chromosome inactivation probably occurs when the total number of haemopoietic stem cell precursors is 14-16. The inactivation patterns found in T lymphocytes were significantly related to those observed in PMNs in both young (P < 0.001) and elderly women (P < 0.01). However, the use of T lymphocytes as a control tissue for distinguishing between skewed inactivation and clonal proliferation proved to be reliable in young females, but not in elderly women, where overestimation of the frequency of clonal myelopoiesis may appear.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D004303 Dosage Compensation, Genetic Genetic mechanisms that allow GENES to be expressed at a similar level irrespective of their GENE DOSAGE. This term is usually used in discussing genes that lie on the SEX CHROMOSOMES. Because the sex chromosomes are only partially homologous, there is a different copy number, i.e., dosage, of these genes in males vs. females. In DROSOPHILA, dosage compensation is accomplished by hypertranscription of genes located on the X CHROMOSOME. In mammals, dosage compensation of X chromosome genes is accomplished by random X CHROMOSOME INACTIVATION of one of the two X chromosomes in the female. Dosage Compensation (Genetics),Gene Dosage Compensation,Hypertranscription, X-Chromosome,X-Chromosome Hypertranscription,Compensation, Dosage (Genetics),Compensation, Gene Dosage,Compensation, Genetic Dosage,Dosage Compensation, Gene,Gene Dosage Compensations,Genetic Dosage Compensation,Genetic Dosage Compensations,Hypertranscription, X Chromosome,X Chromosome Hypertranscription
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods
D006197 Hair A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body. Fetal Hair,Hair, Fetal,Lanugo,Fetal Hairs,Hairs,Hairs, Fetal
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
January 1973, Cytogenetics and cell genetics,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
December 1998, Blood cells, molecules & diseases,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
August 2012, Alcoholism, clinical and experimental research,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
July 2015, Basic and clinical neuroscience,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
May 2005, Arthritis and rheumatism,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
October 2000, Human genetics,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
January 2018, Methods in molecular biology (Clifton, N.J.),
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
January 2001, Postepy higieny i medycyny doswiadczalnej,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
March 1989, Somatic cell and molecular genetics,
L Tonon, and G Bergamaschi, and C Dellavecchia, and V Rosti, and C Lucotti, and L Malabarba, and A Novella, and E Vercesi, and F Frassoni, and M Cazzola
May 1988, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!